Cyclic nucleotides and intracellular‐calcium homeostasis in human platelets
- 1 July 1992
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 207 (2) , 607-613
- https://doi.org/10.1111/j.1432-1033.1992.tb17087.x
Abstract
The relationship between agonist-sensitive calcium compartments and those discharged by the Ca(2+)-ATPase inhibitor thapsigargin were studied in human platelets. In this context, calcium mobilization from intracellular pools and manganese influx was investigated in relation to the effect of altered cyclic-nucleotide levels. For maximal calcium release from intracellular stores, thapsigargin, compared to a receptor agonist like thrombin, requires the platelet's self-amplification mechanism, known to generate thromboxane A2. With this lipid mediator formed, thapsigargin released calcium and stimulated manganese influx in a manner similar to thrombin. Blocking the thromboxane receptor by addition of sulotroban (BM13.177) or, alternatively, increasing platelet cAMP or cGMP using prostacyclin or sodium nitroprusside, dramatically reduced the ability of thapsigargin to release calcium from intracellular compartments. The same experimental conditions significantly reduced the rate of manganese influx initiated by thapsigargin compared to thrombin. The experiments indicate that thapsigargin-sensitive compartments play only a minor role in inducing manganese influx compared to the receptor-sensitive compartment. Cyclic nucleotides accelerate the redistribution of an agonist-elevated platelet calcium into the thapsigargin-sensitive compartment, from which calcium can be released by inhibition of the Ca(2+)-ATPase. In human platelets, thapsigargin-induced calcium increase and influx were responsible for only part the calcium release resulting from inhibition of the corresponding ATPase; another part results from the indirect effect of thapsigargin acting via thromboxane-A2-receptor activation. Cyclic nucleotides are therefore an interesting regulatory device which can modify the thapsigargin response by not allowing the self-amplification mechanism of platelets to operate.Keywords
This publication has 39 references indexed in Scilit:
- The thapsigargin-sensitive intracellular Ca2+ pool is more important in plasma membrane Ca2+ entry than the IP3-sensitive intracellular Ca2+ pool in neuronal cell linesBiochemical and Biophysical Research Communications, 1991
- Calcium mobilization in human platelets by receptor agonists and calcium‐ATPase inhibitorsFEBS Letters, 1991
- Evidence for multiple intracellular calcium pools in GH4C1 cells: Investigations using thapsigarginBiochemical and Biophysical Research Communications, 1991
- The calcium mobilizing and tumor promoting agent, thapsigargin elevates the platelet cytoplasmic free calcium concentration to a higher steady state level. A possible mechanism of action for the tumor promotionBiochemical and Biophysical Research Communications, 1987
- Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human plateletsBiochemical and Biophysical Research Communications, 1986
- Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase CFEBS Letters, 1985
- Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2‐loaded human plateletsFEBS Letters, 1985
- Cyclic amp inhibits platelet activation independently of its effect on cytosolic free calciumBiochemical and Biophysical Research Communications, 1985
- IV. Metabolism of inositides and the activation of plateletsLife Sciences, 1983
- Phosphatidylinositol-specific phospholipase-C of platelets: Association with 1,2-diacylglycerol-kinase and inhibition by cyclic-AMPBiochemical and Biophysical Research Communications, 1979